Yuichiro Kayano - My portal

Profile Information

Affiliation: Hospital Pharmacy, Kyoto University

Degree: 博士（薬学）(北陸大学)

J-GLOBAL ID: 200901086897423219
researchmap Member ID: 6000012431

Research Interests

臨床薬物動態学

Research Areas

Life sciences / Clinical pharmacy /

Research History

2000 - 2007

福井医科大学医学部附属病院薬剤部（現福井大学）
2007

- 富山大学大学院医学薬学研究部
1998 - 1999

福井医科大学医学部附属病院薬剤部（現福井大学）
1999

Pharmacy, Hospital, Kyoto University
1997

金沢大学医学部附属病院薬剤部

Education

- 1992

Faculty of Pharmaceutical Sciences, Hokuriku University

Committee Memberships

2006

日本病院薬剤師会学術第２小委員会

Misc.

Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes

Ishida K, Taira S, Morishita H, Kayano Y, Taguchi M, Hashimoto Y

Biol Pharm Bull., 31(6) 1297-1300, 2008
Additional notes on clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance

Mari Takaai, Yuichiro Kayano, Takako Shimizu, Masato Taguchi, Yukiya Hashimoto

DRUG METABOLISM AND PHARMACOKINETICS, 23(2) 128-133, 2008
Population pharmacokinetics and proton pump inhibitory effects of intravenous lansoprazole in healthy Japanese males

Sakurai Y, Hirayama M, Hashimoto M, Tanaka T, Hasegawa S, Irie S, Ashida K, Kayano Y, Taguchi M, Hashimoto Y

Biol Pharm Bull., 30(12) 2238-2243, 2007
Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance

Ishida K, Kayano Y, Taguchi M, Hashimoto Y

Biol Pharm Bull., 30(11) 2159-2162, 2007
Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese males

Koue T, Kubo M, Funaki T, Fukuda T, Azuma J, Takaai M, Kayano Y, Hashimoto Y

Biol Pharm Bull., 30(11) 2154-2158, 2007
UGT2B7*3 did not affect the pharmacokinetics of R- and S-carvedilol in healthy Japanese

Mutsuko Honda, Wakako Toyoda, Takako Shimizu, Isao Horiuchi, Yuichiro Kayano, Masato Taguchi, Takashi Nozawa, Hiroshi Inoue, Yukiya Hashimoto

DRUG METABOLISM AND PHARMACOKINETICS, 22(5) 382-386, 2007
後発医薬品の安全性情報に関する評価

渡辺享平, 後藤伸之, 塚本仁, 萱野勇一郎, 白波瀬正樹, 中村敏明, 政田幹夫

医薬品情報学, 8(4) 284 – 290, 2007
Clinical Evaluation of Early Post-Marketing Phase Vigilance : Features of Adverse Events Noted in Early Post-marketing Phase Vigilance

Tani Daisuke, Goto Nobuyuki, Kayano Yuichiro, Aono Hironao, Tsukamoto Hitoshi, Yano Ryoichi, Watanabe Kyohei, Shirahase Masaki, Wakiya Yoshifumi, Maeda Sadaaki …

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 31(8) 632-637, 2005
Economic Cost of Treating Adverse Drug Reactions : Estimated Medical Expenditure for the Treatment of Serious Drug-induced Dermopathy Based on MHLW Data

Goto Nobuyuki, Watanabe Kyohei, Yano Ryoichi, Tukamoto Hitoshi, Aono Hironao, Kayano Yuichiro, Wakiya Yoshihumi, Masada Mikio

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 31(5) 399 – 405-405, 2005
Investigation of Early Post-marketing Phase Vigilance Reports

Goto Nobuyuki, Kayano Yuichiro, Watanabe Kyohei, Yano Ryouichi, Tsukamoto Hitoshi, Aono Hironao, Wakiya Yoshihumi, Masada Mikio

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 31(4) 313-319, 2005
Variation in Biological Equivalency Tests among Generic Drugs

Nakamura Toshiaki, Fukuoka Miki, Kayano Yuichirou, Goto Nobuyuki, Wakiya Yoshifumi, Masada Mikio

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 31(2) 158-163, 2005
薬剤疫学(47)市販直後調査の有益性および問題点の検討

谷大輔, 後藤伸之, 萱野勇一郎, 白波瀬正樹, 脇屋義文, 前田定秋, 政田幹夫

医薬品情報学, 6(2) 132 – 133, 2004
Evaluating the Usefulness of Prefilled Syringes with Diluted Heparin

Goto Nobuyuki, Yoshimura Naoto, Kayano Yuichiro, Watanabe Kyohei, Hayashi Miyu, Aoike Miho, Shirahase Masaki, Wakiya Yoshihumi, Masada Mikio

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 28(4) 401-406, 2002
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver

K Watanabe, H Ogi, S Nakamura, Y Kayano, T Matsunaga, H Yoshimura, Yamamoto, I

LIFE SCIENCES, 62(14) 1223-1229, Feb, 1998
Specific expression of ES46.5K, a novel microsomal esterase, in the mouse liver and its catalytic activity for xenobiotic amide and esters

K Watanabe, Y Kayano, T Matsunaga, Yamamoto, I, H Yoshimura

LIFE SCIENCES, 61(14) 1389-1394, Aug, 1997
Involvement of a novel mouse hepatic microsomal esterase, ES46.5K, in the hydrolysis of phthalate esters

Kayano Y, Watanabe K, Matsunaga T, Yamamoto I, Yoshimura H

Biol. Pharm. Bull., 20(7) 749-751, 1997
Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids

Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H

Biol. Pharm. Bull., 19(8) 1109-1111, 1996
Fatty acid conjugates of 11-hydroxy-Δ8-tetrahydrocannabinol: in vitro formation and hydrolysis by the mouse pancreas

Kayano Y, Watanabe K, Matsunaga T, Yamamoto I, Yoshimura H

Res. Commun. Alcohol Subst. Abuse, 17 143 – 149, 1996
A property of a novel esterase (ES46.5K) from mouse hepatic microsomes: hydrolysis of acylated derivatives of 11-hydroxy-Δ8-tetrahydrocannabinol

Kayano Y, Watanabe K, Matsunaga T, Yamamoto I, Yoshimura H

Res. Commun. Alcohol Subst. Abuse, 17 135 – 141, 1996
3,4,5-Trimethoxyphenylacetaldehyde, an intermediate metabolite of mescaline, is a substrate for microsomal aldehyde oxygenase in the mouse liver

Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H

Biol. Pharm. Bull., 18(5) 696-699, 1995

Professional Memberships

Research Projects

臨床薬物動態学